InfuSystem Holdings, Inc. $INFU Holdings Boosted by Minerva Advisors LLC

Minerva Advisors LLC increased its holdings in InfuSystem Holdings, Inc. (NYSE:INFU) by 5.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,078,731 shares of the company’s stock after buying an additional 52,942 shares during the quarter. InfuSystem accounts for about 6.5% of Minerva Advisors LLC’s investment portfolio, making the stock its 4th largest position. Minerva Advisors LLC owned approximately 0.05% of InfuSystem worth $9,676,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in INFU. Cubist Systematic Strategies LLC bought a new stake in InfuSystem during the 1st quarter worth approximately $129,000. Jane Street Group LLC bought a new stake in InfuSystem during the 1st quarter worth approximately $96,000. Acadian Asset Management LLC raised its stake in InfuSystem by 219.1% during the 1st quarter. Acadian Asset Management LLC now owns 39,117 shares of the company’s stock worth $208,000 after acquiring an additional 26,860 shares during the period. American Century Companies Inc. raised its stake in InfuSystem by 147.4% during the 2nd quarter. American Century Companies Inc. now owns 117,812 shares of the company’s stock worth $735,000 after acquiring an additional 70,188 shares during the period. Finally, XTX Topco Ltd bought a new stake in InfuSystem during the 2nd quarter worth approximately $185,000. Institutional investors own 71.13% of the company’s stock.

Analyst Ratings Changes

Separately, Roth Mkm restated a “buy” rating and set a $15.00 target price (up from $14.00) on shares of InfuSystem in a research note on Tuesday, February 24th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $15.00.

InfuSystem Price Performance

NYSE INFU opened at $9.66 on Tuesday. InfuSystem Holdings, Inc. has a 12 month low of $5.08 and a 12 month high of $11.04. The stock has a market cap of $194.96 million, a price-to-earnings ratio of 161.03 and a beta of 1.49. The company’s 50 day moving average is $9.62 and its two-hundred day moving average is $9.15. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50.

InfuSystem announced that its board has initiated a stock repurchase plan on Tuesday, May 19th that authorizes the company to buyback $20.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 10.3% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s board of directors believes its stock is undervalued.

Insider Buying and Selling

In related news, Director Paul Andrew Gendron acquired 5,000 shares of InfuSystem stock in a transaction dated Friday, May 8th. The shares were purchased at an average price of $8.88 per share, for a total transaction of $44,400.00. Following the completion of the transaction, the director directly owned 70,000 shares in the company, valued at approximately $621,600. This represents a 7.69% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Barry G. Steele acquired 7,000 shares of InfuSystem stock in a transaction dated Friday, May 8th. The shares were bought at an average price of $8.71 per share, for a total transaction of $60,970.00. Following the transaction, the chief financial officer owned 96,590 shares of the company’s stock, valued at approximately $841,298.90. The trade was a 7.81% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have acquired 17,064 shares of company stock worth $150,396. 10.80% of the stock is owned by company insiders.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.